CNST - Constellation Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5187.99M
Enterprise Value 3121.83M
Trailing P/E N/A
Forward P/E 1-2.23
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.80
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.58

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-7.01%
S&P500 52-Week Change 32.99%
52 Week High 314.04
52 Week Low 34.01
50-Day Moving Average 37.66
200-Day Moving Average 310.00

Share Statistics

Avg Vol (3 month) 350.99k
Avg Vol (10 day) 3117.33k
Shares Outstanding 525.82M
Float 9.49M
% Held by Insiders 113.33%
% Held by Institutions 182.39%
Shares Short (Aug 15, 2019) 41.14M
Short Ratio (Aug 15, 2019) 436.85
Short % of Float (Aug 15, 2019) 47.42%
Short % of Shares Outstanding (Aug 15, 2019) 44.40%
Shares Short (prior month Jul 15, 2019) 41.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-46.67%
Return on Equity (ttm)-100.00%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -77.34M
Net Income Avi to Common (ttm)-76.08M
Diluted EPS (ttm)-3.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)98.1M
Total Cash Per Share (mrq)3.8
Total Debt (mrq)31.96M
Total Debt/Equity (mrq)47.57
Current Ratio (mrq)5.85
Book Value Per Share (mrq)2.60

Cash Flow Statement

Operating Cash Flow (ttm)-62.55M
Levered Free Cash Flow (ttm)-37.34M